Tension responses of sheep aorta to simultaneous decreases in phosphocreatine, inorganic phosphate and ATP.
- 1 December 1992
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 458 (1) , 139-150
- https://doi.org/10.1113/jphysiol.1992.sp019410
Abstract
1. Tension responses of sheep aortae were investigated when different substrates were included in the superfusing medium. The magnitude of tension development was similar whether or not 5 mM glucose was present in the medium. However, the rate of tension development was greater in the absence of glucose. 2. When 5 mM 2‐deoxyglucose (2DG) was present in the medium, the magnitude of tension generation was 1.6 times that in the absence of exogenous substrate. A second sequential contraction with 2DG generated tension 1.25 times that in the absence of exogenous substrate. The rate of tension development during the first contraction in the presence of 2DG was similar to that in the absence of substrate. However, the second contraction in the presence of 2DG had a substantially increased rate of tension development. 3. 31P nuclear magnetic resonance (NMR) spectroscopy revealed that, at resting tone, in the presence of 2DG, inorganic phosphate (P(i)) and phosphocreatine (PCr) simultaneously decrease while 2‐deoxyglucose‐6‐phosphate accumulates. During contraction‐relaxation cycles, in the presence of 2DG, P(i) and PCr become undetectable while ATP declines to approximately 50% of control values as determined by NMR. During the second contraction in the presence of 2DG, the area of the ADP resonance was similar to that of the alpha‐ATP resonance. 4. The increase in the magnitude of tension generation, during 2DG administration, correlated with a decrease in P(i) levels. The rate of relaxation from a contraction, in the presence of 2DG, was slower than in the presence of glucose or in the absence of exogenous substrate. These results are consistent with the role of P(i) in the release of the proposed ‘latch‐bridge’ state of maintained contraction at low energy demand. 5. The increase in isometric tension generation during contraction in the presence of 2DG appears to be related to the decreased levels of P(i). In the presence of 2DG, the reduction of PCr and of ATP occur to a similar extent to that during hypoxia, yet no inhibition of force takes place. The low levels of ATP and PCr reported with 2DG administration in these studies do not energetically limit the contractile apparatus.Keywords
This publication has 15 references indexed in Scilit:
- Comparison of endogenous and exogenous sources of ATP in fueling Ca2+ uptake in smooth muscle plasma membrane vesicles.The Journal of general physiology, 1992
- Effects of hypoxia on high‐energy phosphagen content, energy metabolism and isometric force in guinea‐pig taenia caeci.The Journal of Physiology, 1990
- Glycogen metabolism during tension generation and maintenance in vascular smooth muscleAmerican Journal of Physiology-Cell Physiology, 1989
- Preferential support of Ca 2+ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascadeThe FASEB Journal, 1989
- Phosphocreatine and oxidative metabolism-contraction coupling in rabbit aortaAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Phosphorous compounds studied by 31P nuclear magnetic resonance spectroscopy in the taenia of guinea‐pig caecum.The Journal of Physiology, 1988
- Effect of inorganic phosphate on the Ca2+ sensitivity in skinned Taenia coli smooth muscle fibers. Comparison of tension, ATPase activity, and phosphorylation of the regulatory myosin light chainsBiophysical Journal, 1987
- Inorganic phosphate regulates the contraction‐relaxation cycle in skinned muscles of the rabbit mesenteric artery.The Journal of Physiology, 1986
- Effects of calcium and substrate on force‐velocity relation and energy turnover in skinned smooth muscle of the guinea‐pig.The Journal of Physiology, 1985
- Inorganic phosphate promotes relaxation of chemically skinned smooth muscle of guinea-pigTaenia coliCellular and Molecular Life Sciences, 1981